Eurofins Scientific SE (ERF.PA)
EUR 54.36
(-1.66%)
EUR 54.36
(-1.66%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.88 Billion EUR | 24.99% |
| 2022 | 3.11 Billion EUR | 24.46% |
| 2021 | 2.5 Billion EUR | -14.29% |
| 2020 | 2.91 Billion EUR | -5.5% |
| 2019 | 3.08 Billion EUR | 11.59% |
| 2018 | 2.76 Billion EUR | 66.43% |
| 2017 | 1.66 Billion EUR | 24.0% |
| 2016 | 1.34 Billion EUR | -10.44% |
| 2015 | 1.49 Billion EUR | 134.55% |
| 2014 | 638.05 Million EUR | -4.32% |
| 2013 | 666.87 Million EUR | 74.1% |
| 2012 | 383.03 Million EUR | -4.4% |
| 2011 | 400.66 Million EUR | 67.89% |
| 2010 | 238.64 Million EUR | 145.31% |
| 2009 | 97.28 Million EUR | -63.12% |
| 2008 | 263.8 Million EUR | 623.14% |
| 2007 | 36.48 Million EUR | -38.21% |
| 2006 | 59.03 Million EUR | -18.17% |
| 2005 | 72.14 Million EUR | 61.35% |
| 2004 | 44.71 Million EUR | 23.9% |
| 2003 | 36.08 Million EUR | -10.42% |
| 2002 | 40.28 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3.37 Billion EUR | -13.27% |
| 2024 Q2 | 3.37 Billion EUR | 0.0% |
| 2023 Q2 | 3.12 Billion EUR | 0.0% |
| 2023 Q3 | 3.32 Billion EUR | 6.29% |
| 2023 FY | 3.88 Billion EUR | 24.99% |
| 2023 Q4 | 3.88 Billion EUR | 16.96% |
| 2023 Q1 | 3.12 Billion EUR | 0.55% |
| 2022 Q2 | 3.08 Billion EUR | 0.0% |
| 2022 Q1 | 3.08 Billion EUR | 23.37% |
| 2022 FY | 3.11 Billion EUR | 24.46% |
| 2022 Q4 | 3.11 Billion EUR | 0.0% |
| 2022 Q3 | 3.11 Billion EUR | 0.88% |
| 2021 Q4 | 2.5 Billion EUR | -0.0% |
| 2021 Q3 | 2.5 Billion EUR | -1.05% |
| 2021 FY | 2.5 Billion EUR | -14.29% |
| 2021 Q2 | 2.52 Billion EUR | 0.0% |
| 2021 Q1 | 2.52 Billion EUR | -13.38% |
| 2020 Q4 | 2.91 Billion EUR | -0.0% |
| 2020 Q3 | 2.91 Billion EUR | -0.5% |
| 2020 FY | 2.91 Billion EUR | -5.5% |
| 2020 Q1 | 2.93 Billion EUR | -5.02% |
| 2020 Q2 | 2.93 Billion EUR | 0.0% |
| 2019 Q2 | 2.66 Billion EUR | 0.0% |
| 2019 Q3 | 3.08 Billion EUR | 15.86% |
| 2019 Q1 | 2.66 Billion EUR | -3.68% |
| 2019 FY | 3.08 Billion EUR | 11.59% |
| 2019 Q4 | 3.08 Billion EUR | 0.0% |
| 2018 Q4 | 2.76 Billion EUR | -0.0% |
| 2018 FY | 2.76 Billion EUR | 66.43% |
| 2018 Q1 | 1.67 Billion EUR | 0.55% |
| 2018 Q2 | 1.67 Billion EUR | 0.0% |
| 2018 Q3 | 2.76 Billion EUR | 65.52% |
| 2017 Q4 | 1.66 Billion EUR | -0.01% |
| 2017 Q3 | 1.66 Billion EUR | 26.52% |
| 2017 Q2 | 1.31 Billion EUR | -0.03% |
| 2017 FY | 1.66 Billion EUR | 24.0% |
| 2017 Q1 | 1.31 Billion EUR | -1.94% |
| 2016 Q4 | 1.34 Billion EUR | -0.12% |
| 2016 Q2 | 1.36 Billion EUR | -0.22% |
| 2016 Q1 | 1.36 Billion EUR | -8.52% |
| 2016 FY | 1.34 Billion EUR | -10.44% |
| 2016 Q3 | 1.34 Billion EUR | -1.76% |
| 2015 FY | 1.49 Billion EUR | 134.55% |
| 2015 Q4 | 1.49 Billion EUR | -0.46% |
| 2015 Q3 | 1.5 Billion EUR | 38.74% |
| 2015 Q2 | 1.08 Billion EUR | -0.85% |
| 2015 Q1 | 1.09 Billion EUR | 71.29% |
| 2014 Q2 | 790.85 Million EUR | -1.81% |
| 2014 Q3 | 650.41 Million EUR | -17.76% |
| 2014 Q4 | 638.05 Million EUR | -1.9% |
| 2014 FY | 638.05 Million EUR | -4.32% |
| 2014 Q1 | 805.47 Million EUR | 20.78% |
| 2013 Q1 | 454.16 Million EUR | 18.57% |
| 2013 Q2 | 438.06 Million EUR | -3.55% |
| 2013 Q4 | 666.87 Million EUR | -2.22% |
| 2013 Q3 | 681.99 Million EUR | 55.68% |
| 2013 FY | 666.87 Million EUR | 74.1% |
| 2012 Q2 | 389.19 Million EUR | 307.82% |
| 2012 FY | 383.03 Million EUR | -4.4% |
| 2012 Q3 | 401.61 Million EUR | 3.19% |
| 2012 Q4 | 383.03 Million EUR | -4.63% |
| 2012 Q1 | 95.43 Million EUR | -76.18% |
| 2011 Q3 | 398.86 Million EUR | 28.68% |
| 2011 Q1 | 311.05 Million EUR | 30.34% |
| 2011 Q2 | 309.96 Million EUR | -0.35% |
| 2011 Q4 | 400.66 Million EUR | 0.45% |
| 2011 FY | 400.66 Million EUR | 67.89% |
| 2010 Q2 | 83.59 Million EUR | -60.66% |
| 2010 FY | 238.64 Million EUR | 145.31% |
| 2010 Q3 | 242.6 Million EUR | 190.23% |
| 2010 Q4 | 238.64 Million EUR | -1.63% |
| 2010 Q1 | 212.47 Million EUR | 118.41% |
| 2009 FY | 97.28 Million EUR | -63.12% |
| 2009 Q4 | 97.28 Million EUR | 300.0% |
| 2009 Q2 | 24.32 Million EUR | 0.0% |
| 2009 Q1 | 24.32 Million EUR | -63.12% |
| 2009 Q3 | 24.32 Million EUR | 0.0% |
| 2008 Q4 | 65.95 Million EUR | 0.0% |
| 2008 Q1 | 65.95 Million EUR | 623.14% |
| 2008 Q3 | 65.95 Million EUR | 0.0% |
| 2008 FY | 263.8 Million EUR | 623.14% |
| 2008 Q2 | 65.95 Million EUR | 0.0% |
| 2007 Q3 | 9.12 Million EUR | 0.0% |
| 2007 Q2 | 9.12 Million EUR | 0.0% |
| 2007 Q4 | 9.12 Million EUR | 0.0% |
| 2007 Q1 | 9.12 Million EUR | -38.21% |
| 2007 FY | 36.48 Million EUR | -38.21% |
| 2006 Q4 | 14.75 Million EUR | 0.0% |
| 2006 Q3 | 14.75 Million EUR | 0.0% |
| 2006 Q2 | 14.75 Million EUR | 0.0% |
| 2006 FY | 59.03 Million EUR | -18.17% |
| 2006 Q1 | 14.75 Million EUR | -18.17% |
| 2005 Q4 | 18.03 Million EUR | 0.0% |
| 2005 Q3 | 18.03 Million EUR | 0.0% |
| 2005 Q2 | 18.03 Million EUR | 0.0% |
| 2005 Q1 | 18.03 Million EUR | 61.35% |
| 2005 FY | 72.14 Million EUR | 61.35% |
| 2004 Q3 | 11.17 Million EUR | 0.0% |
| 2004 Q4 | 11.17 Million EUR | 0.0% |
| 2004 Q2 | 11.17 Million EUR | 0.0% |
| 2004 Q1 | 11.17 Million EUR | 38.38% |
| 2004 FY | 44.71 Million EUR | 23.9% |
| 2003 Q3 | 8.07 Million EUR | 0.0% |
| 2003 Q4 | 8.07 Million EUR | 0.0% |
| 2003 FY | 36.08 Million EUR | -10.42% |
| 2003 Q2 | 8.07 Million EUR | 0.0% |
| 2003 Q1 | 8.07 Million EUR | -13.49% |
| 2002 Q1 | 9.33 Million EUR | 0.0% |
| 2002 Q4 | 9.33 Million EUR | 0.0% |
| 2002 FY | 40.28 Million EUR | 0.0% |
| 2002 Q3 | 9.33 Million EUR | 0.0% |
| 2002 Q2 | 9.33 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Biosynex SA | 59.57 Million EUR | -6428.636% |
| Predilife S.A. | 7.35 Million EUR | -52755.552% |
| bioMérieux S.A. | 355.4 Million EUR | -994.401% |
| Lumibird SA | 121.56 Million EUR | -3099.444% |